Expression of insulin‐like growth factor binding proteins in human breast cancer correlates with estrogen receptor status

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Cellular Biochemistry

• Publication date

  1993-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/JCB.240520211PMID 7690042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human insulin-like growth factor binding protein-6 is O-glycosylated.

  1992cited by this paper
• Prognostic factors and treatment decisions in axillary-node-negative breast cancer.

  1992cited by this paper
• Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.

  1992cited by this paper
• The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer

  1992cited by this paper
• Insulin-like growth factor binding proteins in human breast cancer tissue.

  1992cited by this paper
• Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells.

  1992cited by this paper
• IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma.

  1992cited by this paper
• Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion.

  1992cited by this paper
• Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression.

  1992cited by this paper
• Isolation and molecular cloning of insulin-like growth factor-binding protein-6.

  1991cited by this paper
• Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human.

  1991cited by this paper
• Insulin‐Like growth factor binding protein (IGFBP) inhibits igf action on human osteosarcoma cells

  1991cited by this paper
• IGFBP-1, an insulin like growth factor binding protein, is a cell growth inhibitor.

  1991cited by this paper
• Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein.

  1991cited by this paper
• Growth factors and cancer.

  1991cited by this paper
• Identification of insulin-like growth factor binding proteins in breast cancer cells

  1991cited by this paper
• Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6).

  1991cited by this paper
• A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

  1990cited by this paper
• Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells.

  1990cited by this paper
• Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia.

  1990cited by this paper
• Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status.

  1990cited by this paper
• Insulin-like growth factor binding proteins in human breast cancer cells: relationship to hIGFBP-2 and hIGFBP-3.

  1990cited by this paper
• Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human.

  1990cited by this paper
• Binding proteins for the insulin-like growth factors: structure, regulation and function.

  1989cited by this paper
• Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer.

  1989cited by this paper
• The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells.

  1989cited by this paper
• Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.

  1989cited by this paper
• Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I.

  1989cited by this paper
• Cloning, sequence analysis and expression of a cDNA encoding a novel insulin‐like growth factor binding protein (IGFBP‐2).

  1989cited by this paper
• Insulin-like growth factor II mRNA expression in human breast cancer.

  1988cited by this paper
• Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts.

  1988cited by this paper
• Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma.

  1987cited by this paper
• Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies.

  1986cited by this paper

• Biological effects and regulation of IGFBP5 in breast cancer

  2022cites this paper
• Identifying key multifunctional components shared by critical cancer and normal liver pathways via SparseGMM

  2022cites this paper
• The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative Stress

  2022cites this paper
• Local influence of the corpus luteum on the ipsilateral oviduct and early embryo development in the ewe.

  2020cites this paper
• Current Perspectives on Insulin-like Growth Factor Binding Protein (IGFBP) Research

  2019cites this paper
• The prognostic values of insulin-like growth factor binding protein in breast cancer

  2019cites this paper
• Age and Sex-Related Changes to Gene Expression in the Mouse Spinal Cord

  2019cites this paper
• Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy

  2018cites this paper
• Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade

  2017cites this paper
• A Chip for Estrogen Receptor Action: Detection of Biomarkers Released by MCF-7 Cells through Estrogenic and Anti-Estrogenic Effects

  2017cites this paper
• Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma.

  2016cites this paper
• Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage

  2015cites this paper
• Recent insights into the actions of IGFBP-6

  2015cites this paper
• Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast Cancer

  2015cites this paper
• IGF binding proteins in cancer: mechanistic and clinical insights

  2014cites this paper
• RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy

  2014cites this paper
• Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer

  2014cites this paper
• RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy

  2013cites this paper
• The HER2 amplicon in breast cancer: Topoisomerase IIA and beyond.

  2013cites this paper
• Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.

  2013cites this paper
• Insulin-like growth factor-binding protein-6 and cancer.

  2013cites this paper
• Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women

  2013cites this paper
• Endocrine-Related Cancer ( 2011 ) 18 235 – 244 IGF 1 and risk of additional breast cancer in the WHEL study

  2011cites this paper
• IGF1 and risk of additional breast cancer in the WHEL study.

  2011cites this paper
• Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.

  2010cites this paper
• Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients.

  2010cites this paper
• Apple Phytochemicals In The Prevention Of Breast Cancer: Effects On Cell Proliferation And Apoptosis

  2009cites this paper
• Effects of endogenous insulin-like growth factor binding protein-3 on cell cycle regulation in breast cancer cells

  2009influential citation
• Insulin-like growth factor-binding protein-3 in breast cancer: analysis with tissue microarray.

  2009cites this paper
• Histone deacetylase inhibitor induced modulation of anti-estrogen therapy.

  2009cites this paper
• Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer

  2008cites this paper
• IGF Binding Proteins (IGFBPs) and Regulation of Breast Cancer Biology

  2008cites this paper
• Crosstalk Between IGF1R and Estrogen Receptor Signaling in Breast Cancer

  2008cites this paper
• Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer.

  2007cites this paper
• IGFBP3 mRNA expression in benign and malignant breast tumors

  2007cites this paper
• Insulin-like growth factor binding proteins and breast cancer

  2007cites this paper
• Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer.

  2007cites this paper
• Inhibitors of Insulin-like Growth Factor Signaling: A Therapeutic Approach for Breast Cancer

  2006cites this paper
• Inhibition in Human Breast Cancer Cells 2-induced Growth β Acid-and Transforming Growth Factor Insulin-like Growth Factor Binding Protein 3 Mediates Retinoic Updated

  2006cites this paper
• Parous mammary glands exhibit distinct alterations in gene expression and proliferation responsiveness to carcinogenic stimuli in Lewis rats.

  2006cites this paper
• Advances in Brief Sequence Alterations of Insulin-like Growth Factor Binding Protein 3 in Neoplastic and Normal Gastrointestinal Tissues 1

  2006cites this paper
• Biology of insulin-like growth factor binding protein-4 and its role in cancer (review).

  2006cites this paper
• Endometriosis-specific genes identified by real-time reverse transcription-polymerase chain reaction expression profiling of endometriosis versus autologous uterine endometrium.

  2006cites this paper
• Insulin-like Growth Factor Binding Protein-3 and Insulin Receptor Substrate-i in Breast Cancer: Correlation with Clinical Parameters and Disease-free Survival1

  2005cites this paper
• Role of TGF-β and IGF in Tumor Progression and Bone Metastases

  2005cites this paper
• Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells.

  2005cites this paper
• Insulin-like Growth Factor Binding Protein 1 Expression Inhibits Insulin-like Growth Factor I Action in MCF-7 Breast Cancer Cells 1

  2005cites this paper
• The insulin-like growth factor system as a target in breast cancer

  2004cites this paper
• Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome

  2004cites this paper
• Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update

  2004cites this paper
• Crosstalk Between the Insulin-Like Growth Factors and Estrogens in Breast Cancer

  2004cites this paper
• The Insulin-Like Growth Factor (IGF) Family and Breast Cancer

  2003cites this paper
• IGFBPs and Breast Cancer

  2003influential citation
• Estrogen receptor (ER) β1 and ERβcx/β2 inhibit ERα function differently in breast cancer cell line MCF7

  2003cites this paper
• The GH-IGF-I axis and breast cancer.

  2003cites this paper
• Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7.

  2003cites this paper
• Suppression of mammary gland tumorigenesis in diabetic rats.

  2003cites this paper
• Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer.

  2002cites this paper
• Role of insulin‐like growth factor binding protein‐3 in breast cancer cell growth

  2002cites this paper
• PII: S0361-090X(02)00028-4

  2002cites this paper
• Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes

  2002cites this paper
• Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism.

  2002cites this paper
• Effect of Breast Surgery on Serum Levels of Insulin-Like Growth Factors (IGF-I, IGF-II, and IGF Binding Protein-3) in Women With Benign and Malignant Breast Lesions

  2001cites this paper
• mRNA expression patterns of insulin‐like growth factor system components in human neuroendocrine tumours

  2000cites this paper
• Tyrosine kinase signalling in breast cancer: Insulin-like growth factors and their receptors in breast cancer

  2000cites this paper
• Role of the insulin-like growth factor family in cancer development and progression.

  2000cites this paper
• Insulin-Like Growth Factor Binding Proteins in Endocrine-Related Neoplasia

  2000cites this paper
• Transcriptional activation of insulin-like growth factor-binding protein-4 by 17beta-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes.

  1999cites this paper
• Angiogenic growth factors in preinvasive breast disease.

  1999cites this paper
• Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule.

  1999cites this paper
• Transcriptional Activation of Insulin-Like Growth Factor-Binding Protein-4 by 17β-Estradiol in MCF-7 Cells: Role of Estrogen Receptor-Sp1 Complexes.

  1999cites this paper
• Serum levels of insulin-like growth factor binding protein-3 in benign and malignant breast disease.

  1999cites this paper
• Angiogenic Growth Factors in Preinvasive Breast Disease 1

  1999cites this paper
• Potential role of insulin‐like growth factor binding protein‐4 in the uncoupling of bone turnover in multiple myeloma

  1999cites this paper
• IGF-I and retinoic acid regulate the distribution pattern of IGFBPs synthesized by the canine mammary tumor cell line CMT-U335

  1999cites this paper
• Role of the IGF System in Breast Cancer Proliferation and Progression

  1999cites this paper
• Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues.

  1998cites this paper
• Characterization and regulation of insulin‐like growth factor binding proteins in human hepatic stellate cells

  1998cites this paper
• Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study.

  1998cites this paper
• Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas

  1998cites this paper
• Igf-independent regulation of breast cancer growth by IGF binding proteins

  1998cites this paper
• Differential expression of insulin-like growth factor binding proteins in high versus low Gleason score prostate cancer.

  1998cites this paper
• Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.

  1998cites this paper
• Effects of aromatase complex selective inhibition on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 circulating levels in breast cancer.

  1997cites this paper
• IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth.

  1997cites this paper
• Insulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions

  1997cites this paper
• Steroid hormones in endometrial and breast cancer. Review.

  1997cites this paper
• Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.

  1997cites this paper
• IGFBPs and neoplastic models

  1997cites this paper
• Growth factors and cytokines in health and disease: Breast cancer

  1997cites this paper
• Growth Factors and Growth Factor Inhibitors

  1997cites this paper
• Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.

  1996cites this paper
• Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089.

  1996cites this paper
• Insulin-like growth factor receptors and binding proteins.

  1996cites this paper
• Insulin-like Growth Factor Binding Protein 3 Mediates Retinoic Acid- and Transforming Growth Factor β2-induced Growth Inhibition in Human Breast Cancer Cells

  1996cites this paper
• Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.

  1996cites this paper
• Characterization of insulin-like growth factor binding proteins and regulation of IGFBP3 in human mesangial cells.

  1996cites this paper
• Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.

  1996cites this paper
• Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop.

  1995cites this paper
• Insulin-like growth factors and breast cancer.

  1995cites this paper